Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD001505.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Larry C Lands

    Correspondencia a: Department of Pediatrics, Montreal Children's Hospital, Montreal, Canada

    [email protected]

  • Sanja Stanojevic

    CHild Health Evaluative Sciences & Respiratory Medicine, The Hospital for Sick Children, Toronto, Canada

Contributions of authors

Anna Crighton had the original idea for the review, drafted the protocol, extracted data and co‐authored the review. Carol Dezateux drafted the protocol and data extraction forms, extracted and analyzed data and was responsible for writing the review.

Anna Crighton and Carol Dezateux stepped down from the review as from February 2006.

Larry Lands took over as lead reviewer in May 2004. He led on the update of the review and acts as guarantor of the review.

Sanja Stanojevic joined the review in June 2006. She extracted and analyzed data for the subsequent updates and co‐authored the review.

Sources of support

Internal sources

  • Institute of Child Health, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.

External sources

  • Tenovus, Scotland, UK.

Declarations of interest

disponible en

Dr Larry Lands was the lead investigator in the Trans‐Canadian Trial (Lands 2007).

Acknowledgements

disponible en

We are grateful to Professor Rosalind Smyth, Jill Motley, Nikki Jahnke and the Cochrane Cystic Fibrosis and Genetic Disorders Editorial Group for their invaluable support; to Professor Carol Dezateux and Anna Crighton for their input into previous versions of this review; to Dr Michael Konstan for his helpful comments on an earlier draft of the original review; and to Dr Somnath Mukhopadhyay for his encouragement.

Version history

Published

Title

Stage

Authors

Version

2019 Sep 09

Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis

Review

Larry C Lands, Sanja Stanojevic

https://doi.org/10.1002/14651858.CD001505.pub5

2016 Apr 07

Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis

Review

Larry C Lands, Sanja Stanojevic

https://doi.org/10.1002/14651858.CD001505.pub4

2013 Jun 13

Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis

Review

Larry C Lands, Sanja Stanojevic

https://doi.org/10.1002/14651858.CD001505.pub3

2007 Oct 17

Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis

Review

Larry C Lands, Sanja Stanojevic

https://doi.org/10.1002/14651858.CD001505.pub2

1999 Apr 26

Oral non‐steroidal anti‐inflammatory drug therapy for cystic fibrosis

Review

Larry C Lands, Carol Dezateux, A Crighton, Sanja Stanojevic

https://doi.org/10.1002/14651858.CD001505

Differences between protocol and review

There was a post‐hoc subgroup analysis of the lung function data split by age (two groups: 'under 13 years at randomisation' and '13 years and over at randomisation').

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.